- Release Date: 22/07/25 14:57
- Summary: Application for quotation of securities - PAR
- Price Sensitive: No
- Download Document 15.51KB
- Forums
- ASX - By Stock
- PAR
- Ann: Application for quotation of securities - PAR
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
3.39%
!
30.5¢

Ann: Application for quotation of securities - PAR
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
30.5¢ |
Change
0.010(3.39%) |
Mkt cap ! $121.2M |
Open | High | Low | Value | Volume |
29.5¢ | 30.8¢ | 29.5¢ | $110.4K | 368.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 118440 | 30.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.0¢ | 25841 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 118440 | 0.300 |
15 | 383247 | 0.295 |
18 | 402708 | 0.290 |
6 | 53147 | 0.285 |
9 | 253912 | 0.280 |
Price($) | Vol. | No. |
---|---|---|
0.310 | 25841 | 2 |
0.325 | 93650 | 4 |
0.330 | 84717 | 6 |
0.335 | 35982 | 4 |
0.340 | 277110 | 4 |
Last trade - 16.10pm 21/08/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, MD & CEO
Michael Thurn
MD & CEO
SPONSORED BY The Market Online